Data partnerships
Helping clinics to realize the power of their imaging data Healthcare has always needed data to self-regulate and improve. Data in all...
top of page
Mirada adds to growing library of anatomical structures
Here at Mirada we are excited to announce the release of 13 new abdominal structures to DLCExpert, our AI-powered auto contouring...
Mirada works with NHS on second AI Award
Your Patient Communications Editor Introducing our patient communications initiative Mirada Medical continues to work on its second AI...
Minister for Innovation: Mirada UK leader in AI-powered medical technology
Mirada Medical recognised by Lord Bethell for enhancing cancer care with innovative Artificial Intelligence (AI) technology Oxford, 17...
Mirada announces ‘à la carte’ library of structures for DLCExpert™
New updates will empower healthcare organizations around the globe to access AI-powered contouring in line with their unique treatment...
Nearly 50 cancer charities send a stark warning about the impact of Covid-19
Cancer death rate will rise for the first time in decades Hugh Bettesworth, CEO, Mirada Medical One Cancer Voice coalition’s warning that...
Take The Turing Game Challenge
Machine drawn or drawn by a trained clinician? You tell us. Organs at risk contouring can be automated but are these contours good...
Mirada Medical sees record year as it helps fight COVID-19 backlog
1ST JUNE 2021 LONDON Mirada Medical, the leading international brand in cancer treatment software, has seen record growth over the last...
Mirada Medical heralds ‘step change’ in the use of artificial intelligence for cancer care
with the launch of its Workflow Box 2.6 platform update OXFORD 21ST JULY 2021 The improvements represent another step-change in the...
Mirada hires Dr Mark Crockett as its new Chief Medical Officer
Oxford, 22nd September 2021: Mirada Medical today announced the appointment of Dr Mark Crockett as its new Chief Medical Officer (CMO)....
Unlocking the potential of AI - UK Report
DOWNLOAD THE REPORT How is AI used in Oncology departments in the UK? It’s nearly three years since the government unveiled its Long Term...
Mirada Medical Appoints Jon DeVries as CEO
DeVries to accelerate growth and expand vision for deep learning applications in cancer care Oxford, 15th September 2021: Mirada Medical...
Mirada recognized as a Top 100 Digital Health Company by the DIT
New initiative that recognizes the UK’s leading digital health organizations By Hugh Bettesworth, CEO, Mirada Medical I am excited to...
Advancing Automation with AI Technologies for Precise Cancer Care Treatment–A fireside chat GE
Here at Mirada Medical, we are excited to continue to grow our relationship with GE Healthcare. We share a commitment to delivering...
RefleXion Announces Licensing Agreement with Mirada Medical to Advance Personalized Cancer Treatment
Rapid, adaptive radiotherapy treatment plans hold potential to reduce toxicity and improve patient outcomes HAYWARD, Calif., July 7, 2022...
Apposite Capital Makes Further Investment in Mirada Medical to Advance Precision Cancer Care
London, UK – 8th June 2022. Apposite Capital, the healthcare specialist private equity investor, today announces that it has made a...
Sorna Corporation Now Offering PET/CT Fusion Viewer
EAGAN, MN – June 8, 2022– Sorna Corporation continues to innovate enterprise imaging with the announcement of its partnership with Mirada...
Pioneering Personalized Cancer Care – Article with Healthcare Tech
Mirada Medical Pioneering Personalized Cancer Care “Everybody’s cancer is unique, requiring a personalized and precise treatment,” says...